Albert Matalon

Biosketch / Results /

Albert Matalon

Clinical Assistant Professor, Department of Medicine

Contact Info

212/263-7239

Education

1991-1995 — NYU School of Medicine, Medical Education
1995-1998 — Long Island Jewish Medical Center (Internal Medicine), Residency Training
1998-2000 — Columbia-Presbyterian Medical Center, Clinical Fellowships
1998-2000 — Columbia Presbysterian Medical Center (Nephrology), Clinical Fellowships

Research Interests

Dialysis; Treament of Anemia; Prevention of dialysis-related infection; Familial Dysautonomia; Fabry Disease

Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study
Fattom, Ali; Matalon, Albert; Buerkert, John; Taylor, Kimberly; Damaso, Silvia; Boutriau, Dominique. Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study. Human vaccines & immunotherapeutics. 2015 ;11(3):632-641 (1565642)

Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study
Vemuri, Nirupama; Michelis, Michael F; Matalon, Albert. Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study. BMC nephrology. 2011 Sep 30;12:49-49 (140550)

Renal transplantation in familial dysautonomia: report of two cases and review of the literature
Rekhtman, Yelena; Bomback, Andrew S; Nash, Martin A; Cohen, Scott D; Matalon, Albert; Jan, Dominique M; Kaufmann, Horacio; Axelrod, Felicia B; Radhakrishnan, Jai; Appel, Gerald B. Renal transplantation in familial dysautonomia: report of two cases and review of the literature. Clinical journal of the American Society of Nephrology : CJASN. 2010 Jun 17;5(9):1676-1680 (138213)

CaSR polymorphism Arg990Gly and response to calcimimetic agents in end-stage kidney disease patients with secondary hyperparathyroidism and in cell culture
Rothe, H; Shapiro, W; Sun, WY; Matalon, A. CaSR polymorphism Arg990Gly and response to calcimimetic agents in end-stage kidney disease patients with secondary hyperparathyroidism and in cell culture. Personalized medicine. 2008 MAR ;5(2):109-116 (90771)

Genetic make-up of calcium-sensing receptor polymorphic position 990 and parameters of secondary hyperparathyroidism in haemodialysis centres from New York and Innsbruck
Rothe, H; Mayer, G; Eller, P; Matalon, A. Genetic make-up of calcium-sensing receptor polymorphic position 990 and parameters of secondary hyperparathyroidism in haemodialysis centres from New York and Innsbruck [Meeting Abstract]. Nephrology, dialysis, transplantation. 2007 NOV ;22(11):191-191 (87123)